Tocilizumab linked with highest risk for neutropenia in comparison study that included abatacept, infliximab

Press/Media

Period	21 Apr 2017

Media coverage

Title	Tocilizumab linked with highest risk for neutropenia in comparison study that included abatacept, infliximab
Media name/outlet	Healio
Country/Territory	United States
Date	21/04/17
URL	www.healio.com/rheumatology/practice-management/news/online/%7bdda6be31-ef05-4caa-8b9b-71b36de336bd%7d/tocilizumab-linked-with-highest-risk-for-neutropenia-in-comparison-study-that-included-abatacept-infliximab
Persons	Francisco Espinoza